Sandra L Spoelstra1, Charles W Given2, Alla Sikorskii3, Constantinos K Coursaris4, Atreyee Majumder3, Tracy DeKoekkoek1, Monica Schueller1, Barbara A Given1. 1. College of Nursing, Michigan State University, East Lansing, Michigan, USA. 2. Institute for Health Care Studies, Michigan State University, East Lansing, Michigan, USA. 3. Department of Statistics and Probability, Michigan State University, East Lansing, Michigan, USA. 4. Department of Telecommunication, Information Studies (Dr. Coursaris), Michigan State University, East Lansing, Michigan, USA.
Abstract
AIM: The aim of this study was to report a study protocol that examines feasibility, preliminary efficacy and satisfaction of a text message intervention on the outcome of medication adherence in adult patients prescribed oral anti-cancer agents. BACKGROUND: Administration of oral anti-cancer agents occurs in the home setting, requiring patients to self-manage the regimen as prescribed. However, many barriers to medication adherence exist: regimens are often complex, with cycling of two or more medications; side effects of treatment; most cancer patients are older with comorbid conditions and competing demands; and cognitive decline and forgetfulness may occur. Research indicates patients miss nearly one-third of the prescribed oral anti-cancer agent dosages. Text message interventions have been shown to improve medication adherence in chronic conditions other than cancer. However, a majority of those patients were less than 50 years of age and most cancer patients are diagnosed later in life. DESIGN: A two-group randomized controlled trial with repeated measures. METHODS:Seventy-five adult patients newly prescribed an oral anti-cancer agent will be recruited (project funded in April 2013) from community cancer centres and a specialty pharmacy. Participants will be randomized to either a control group (n = 25; usual care) or an intervention group (n = 50; usual care plus text messages timed to medication regimen). Outcome measures include: medication adherence, feasibility and satisfaction with the intervention. Data will be collected over 8 weeks: baseline, weekly and exit. DISCUSSION: Standardized text message intervention protocol and detailed study procedures have been developed in this study to improve medication adherence.
RCT Entities:
AIM: The aim of this study was to report a study protocol that examines feasibility, preliminary efficacy and satisfaction of a text message intervention on the outcome of medication adherence in adult patients prescribed oral anti-cancer agents. BACKGROUND: Administration of oral anti-cancer agents occurs in the home setting, requiring patients to self-manage the regimen as prescribed. However, many barriers to medication adherence exist: regimens are often complex, with cycling of two or more medications; side effects of treatment; most cancerpatients are older with comorbid conditions and competing demands; and cognitive decline and forgetfulness may occur. Research indicates patients miss nearly one-third of the prescribed oral anti-cancer agent dosages. Text message interventions have been shown to improve medication adherence in chronic conditions other than cancer. However, a majority of those patients were less than 50 years of age and most cancerpatients are diagnosed later in life. DESIGN: A two-group randomized controlled trial with repeated measures. METHODS: Seventy-five adult patients newly prescribed an oral anti-cancer agent will be recruited (project funded in April 2013) from community cancer centres and a specialty pharmacy. Participants will be randomized to either a control group (n = 25; usual care) or an intervention group (n = 50; usual care plus text messages timed to medication regimen). Outcome measures include: medication adherence, feasibility and satisfaction with the intervention. Data will be collected over 8 weeks: baseline, weekly and exit. DISCUSSION: Standardized text message intervention protocol and detailed study procedures have been developed in this study to improve medication adherence.
Authors: Najla A Lakkis; Alaa M A Atfeh; Youssef R El-Zein; Dina M Mahmassani; Ghassan N Hamadeh Journal: Prev Med Date: 2011-08-16 Impact factor: 4.018
Authors: F Bassan; F Peter; B Houbre; M J Brennstuhl; M Costantini; E Speyer; C Tarquinio Journal: Eur J Cancer Care (Engl) Date: 2013-09-15 Impact factor: 2.520
Authors: Sandra L Spoelstra; Charles W Given; Alla Sikorskii; Atreyee Majumder; Monica Schueller; Barbara A Given Journal: Oncol Nurs Forum Date: 2015-01 Impact factor: 2.172
Authors: Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker Journal: J Pain Symptom Manage Date: 2007-12-26 Impact factor: 3.612
Authors: Sandra L Spoelstra; Charles W Given; Alla Sikorskii; Constantinos K Coursaris; Atreyee Majumder; Tracy DeKoekkoek; Monica Schueller; Barbara A Given Journal: Telemed J E Health Date: 2015-12-30 Impact factor: 3.536
Authors: Ann M Mazzella Ebstein; Margaret Barton-Burke; Venice Anthony; Andrea Smith; Zhigang Zhang; Mark Robson Journal: J Adv Nurs Date: 2020-11-27 Impact factor: 3.187